Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chipotle Mexican Grill, Inc. (CMG) vs Twist Bioscience Corp (TWST) Price & Performance

Chipotle Mexican Grill, Inc.Trade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Chipotle Mexican Grill, Inc. vs Twist Bioscience Corp — how do they compare? Chipotle Mexican Grill, Inc. trades at $32.33 (market cap $40.49B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Chipotle Mexican Grill, Inc. is far larger — about 5.2× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Chipotle Mexican Grill, Inc. nearer its low. Which is the better fit depends on your goals.

CMGTWST
Market Cap
$40.49B$7.72B
Sector
Consumer CyclicalHealth
52-Week High
$44.04$124.88
52-Week Low
$28.17$24.16
Enterprise Value
$45.24B$7.65B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Chipotle Mexican Grill, Inc.

Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.

Read more on CMG

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST